ImmuPharma plc (AIM: IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 2.822
-0.258 (-8.39%)
Jan 22, 2025, 12:10 PM GMT+1
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 12.83 million as of January 22, 2025. Its market cap has increased by 88.73% in one year.
Market Cap
12.83M
Enterprise Value
11.74M
Revenue
-69.96K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.82
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 12.83M, a decrease of -64.48%. That is a compound annual growth rate of -5.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.60B |
| GSK plc | 55.45B |
| Haleon | 33.80B |
| Smith & Nephew | 8.94B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 4.63B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |